BiotechTube
Home/Pipeline/Injection Form Development

Injection Form Development

Various

Not DisclosedActive

Key Facts

Indication
Various
Phase
Not Disclosed
Status
Active
Company
Polpharma

About Polpharma

Polpharma is a dominant, privately-held generic drug manufacturer in Poland and a key regional player in CEE and CIS markets. With over 4,300 employees, five manufacturing plants, and three R&D centers, it produces approximately 400 million medicine packages annually, holding a ~12.5% share of the Polish pharmacy market and a ~33% share of the hospital market. The company is expanding its international presence, notably with a new office in India, and is investing in innovative drug development in areas like ophthalmology and asthma while maintaining a strong foundation in generics and APIs.

View full company profile

Therapeutic Areas

Broad GenericsOphthalmologyAsthmaHospital Care

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
CBD/THC Oil FormulationAvecho BiotechnologyPreclinical
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing